These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 2851893)
1. [Detection of pre-S gene products in HBsAg carriers and in hepatitis B vaccines]. Gerken G; Manns M; Kyriatsoulis A; Hess G; Meyer zum Büschenfelde KH Z Gastroenterol; 1988 Jul; 26(7):374-9. PubMed ID: 2851893 [TBL] [Abstract][Full Text] [Related]
2. Interactions of hepatitis B virus with hepatocytes: mechanism and clinical relevance. Theilmann L; Goeser T Hepatogastroenterology; 1991 Feb; 38(1):10-3. PubMed ID: 1709133 [TBL] [Abstract][Full Text] [Related]
3. Polypeptides coded for by the region pre-S and gene S of hepatitis B virus DNA with the receptor for polymerized human serum albumin: expression on hepatitis B particles produced in the HBeAg or anti-HBe phase of hepatitis B virus infection. Takahashi K; Kishimoto S; Ohnuma H; Machida A; Takai E; Tsuda F; Miyamoto H; Tanaka T; Matsushita K; Oda K J Immunol; 1986 May; 136(9):3467-72. PubMed ID: 3007621 [TBL] [Abstract][Full Text] [Related]
4. Western blot analysis of the reactivity between envelope proteins of hepatitis B viruses from Brazilian carriers and antibodies raised against recombinant hepatitis B vaccines. De Castro L; Yoshida CF; Gaspar AM; Gomes SA Acta Virol; 1996; 40(5-6):251-8. PubMed ID: 9171452 [TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of a new mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in adults. Raz R; Koren R; Bass D Isr Med Assoc J; 2001 May; 3(5):328-32. PubMed ID: 11411195 [TBL] [Abstract][Full Text] [Related]
6. New vaccination strategies for low- and non-responders to hepatitis B vaccine. Rendi-Wagner P; Wiedermann G; Stemberger H; Kollaritsch H Wien Klin Wochenschr; 2002 Mar; 114(5-6):175-80. PubMed ID: 12238305 [TBL] [Abstract][Full Text] [Related]
7. An affordable multideterminant plasma-derived hepatitis B virus vaccine. Prince AM; Vnek J; Brotman B IARC Sci Publ; 1984; (63):355-72. PubMed ID: 6085626 [TBL] [Abstract][Full Text] [Related]
8. Detection of antibodies against pre-S1 proteins in sera of patients with hepatitis B virus infection by ELISA using a pre-S fusion protein expressed in E. coli. Theilmann L; Burkhardt HD; Galle PR; Gmelin K; Kommerell B; Pfaff E Arzneimittelforschung; 1988 Dec; 38(12):1856-8. PubMed ID: 3072959 [TBL] [Abstract][Full Text] [Related]
10. A brief overview of the new vaccines against hepatitis B virus infection: immunogenic gene products and peptide analogues of antigenic epitopes. Vyas GN Dev Biol Stand; 1986; 63():141-6. PubMed ID: 2427376 [TBL] [Abstract][Full Text] [Related]
11. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2]. Romanò L; Biffi R; Bianchi S; Zanetti A Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407 [No Abstract] [Full Text] [Related]
12. Anti-pre-S2 antibodies in natural hepatitis B virus infection and after immunization. Coursaget P; Adamowicz P; Bourdil C; Yvonnet B; Buisson Y; Barrès JL; Saliou P; Chiron JP; Mar ID Vaccine; 1988 Aug; 6(4):357-61. PubMed ID: 2973189 [TBL] [Abstract][Full Text] [Related]
13. [Active immunoprophylaxis of type B viral hepatitis. Evaluation of the effectiveness of HEVAC-B vaccine in a population at risk]. Tarocco RP; Faro G; Sargiotto A; Visconti C Minerva Med; 1987 Aug; 78(16):1233-41. PubMed ID: 2957614 [TBL] [Abstract][Full Text] [Related]
14. Vaccination against hepatitis B virus infection in neonates. Pongpipat D; Suvatte V; Assateerawatts A Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis B surface antigen/IgM complexes: relation to receptors for polymerized human serum albumin, hepatitis B virus (HBV) DNA polymerase activity and HBV markers. Mora I; Carreño V; Porres JC; Gutiez J; Guio CH Acta Virol; 1987 Mar; 31(2):116-25. PubMed ID: 2886020 [TBL] [Abstract][Full Text] [Related]
16. [Humoral immunological response in laboratory animals after vaccination with recombinant vaccines against viral hepatitis B of different generations]. Górska P Przegl Epidemiol; 2007; 61(2):393-400. PubMed ID: 17956059 [TBL] [Abstract][Full Text] [Related]
17. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen. Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161 [TBL] [Abstract][Full Text] [Related]
18. Point mutations in the S and pre-S2 genes observed in two hepatitis B virus carriers positive for antibody to hepatitis B surface antigen. Shinji T; Koide N; Hanafusa T; Hada H; Oka T; Takayama N; Shiraha H; Nakamura M; Ujike K; Yumoto Y; Tsuji T Hepatogastroenterology; 1998; 45(20):500-2. PubMed ID: 9638436 [TBL] [Abstract][Full Text] [Related]
19. Antibody response to preS1 in hepatitis-B-virus-induced liver disease and after immunization. Coursaget P; Buisson Y; Bourdil C; Yvonnet B; Molinié C; Diop MT; Chiron JP; Bao O; Diop-Mar I Res Virol; 1990; 141(5):563-70. PubMed ID: 2148981 [TBL] [Abstract][Full Text] [Related]
20. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial. Xu ZY; Liu CB; Francis DP; Purcell RH; Gun ZL; Duan SC; Chen RJ; Margolis HS; Huang CH; Maynard JE Pediatrics; 1985 Nov; 76(5):713-8. PubMed ID: 3903646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]